Skip to main content

Shionogi & Co. Value Stock - Dividend - Research Selection

Shionogi & Co., Ltd.

ISIN: JP3347200002, WKN: 855648

Market price date: 18.09.2020
Market price: 5.868,00 JPY




Shionogi & Co., Ltd. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 01-06-2020
Cash flow
Net operating cash flow 129.138.000.000
Capital Expenditures -9.014.000.000
Free cash flow 120.123.998.208
Balance sheet
Total Equity 683.647.000.000
Liabilities & Shareholders equity 773.650.000.000
Income statement
Net income 121.295.000.000
Eps (diluted) 392,380
Diluted shares outstanding 309.126.000
Net sales/revenue 334.958.000.000

Fundamental ratios calculated on: 18-09-2020

Ratios
Key figures 18-09-2020
Cash flow
P/C 14,05
   
P/FC 15,10
Balance sheet
ROI15,68
ROE88,37
Income statement
P/E14,96
Div. Yield1,76%
P/B2,65
P/S5,42


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol4507.TSE
Market Capitalization17.488.588.800,00 USD
CountryJapan
IndicesNIKKEI 225
SectorsPharma
Raw Data SourceIFRS in Millionen JPY
Stock Split
Internetwww.shionogi.co.jp


Description of the company

Shionogi & Co., Ltd. is a pharmaceutical company based in Japan. It is engaged in the research, development, purchasing, manufacturing and sale of pharmaceuticals and pharmaceutical companies. The company mainly offers vitamin supplements, analgesic antipyretics, cold and sinus remedies, digestive medicine, dermatological preparations, anti-inflammatory drugs, antihypercholesterolemics, urine glucose test papers and artificial tooth-like products. As of March 31, 2014, the Company had 37 subsidiaries and six associates.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.shionogi.co.jp